Business · 16/03/2009

FDA Releases Draft Guidance on User Fees and Refunds for PMAs

The Food and Drug Administration (FDA) has released a draft guidance document outlining user fees and refunds for Premarket Approval Applications (PMAs), including supplements and other submissions. The document aims to clarify the types of PMAs subject to user fees and the conditions under which a refund may be granted.